Just like LSD, MDMA (which is ecstasy) Ketamine is a bigpharma product of the previous century. It is thus not a plant medicine but does cause hallucinations.
Ketamine stands apart from similar medicines because of its unique properties and position within the world of psychedelics. Its effects are a combination of qualities similar to other psychedelic and natural medicines—it’s an analgesic like cannabis, an anesthetic like kambo, can have euphoric effects like MDMA, and induces deep visionary experiences like ibogaine or ayahuasca. (psychedelic times)
Aldous Huxley's Dystopian dream was to have a fully medicated society, and his dream might just be on its way to come true. Even though our society already is medicated with porn, alcohol, cannabis, and other drugs illegal and prescription drugs, we definitely are at crossroads again.
Pharmaceuticals have embarked on the quest for manipulating our emotions with psychedelics. A brain that can think for itself is subversive and needs to be controlled. The growing success of Ayahuasca and Iboga especially opened the door to the legalization of these plant medicines because of their strong healing properties.
Ayahuasca Retreats and Churches have begun to pop up nationwide and it's very easy to find them on google today. Even though their services have gotten a little pricier over time, one still can save the airfare to Latin America. People healing themselves with the help of shamanic mentors is not acceptable according to pharmaceutical consensus because that represents billions of dollars in market losses.
Neuroscience would rather see us like machines with switches that can be turned on and off at will. The dream has come true with ketamine.
The drug war being lost, the only solution was to show strong support of psychedelics and start the takeover of the trend, while claiming the virtues of science as a savior. Neuroscience is racing to control our emotions and reactions and ketamin is getting the most attention. But why?
The psychedelic switch is set to become the new pharmaceutical Eldorado and you will see that soon enough, microdosing of ketamine available for all kinds of traumas and depression. The drug Esketamine is already on the market. Science does not care at all about indigenous knowledge and practices at all. Plant medicines will remain part of the alternative research.
Since it is glutamate that regulates the level of ego-dissolution, studies can now move forward while removing any plant-based knowledge, bypassing Nature. Science is very good at thinking it can do better than Nature. Just look at the state of the planet... so how is this going to end again?
The article encouraging the use of Ketamine and cannabis is another eye-opener telling us that neuroscientists regard society as a rat race and will push imbalances so that individuals do not only become even more dependent on prescription drugs but more and more separate from the spiritual realm. Just in case you didn't know ketamine is also a top drug rape. Indeed, what could go wrong since addiction to ketamine is a fact now?
Turning the psychedelics into another industry is exactly what we feared a few years ago. And the only way to stop this is to realize that a for-profit society isn't the answer.
- A new analysis in The British Journal of Psychiatry claims the FDA approval process for ketamine was rushed.
- Only one of three clinical trials showed efficacy, while the discontinuation trial produced troubling outcomes.
- Ketamine's side effects include anxiety, poor appetite, delusions, hallucinations, paranoia, rage, and craving.
23 May 2020 Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. There is growing interest in the therapeutic utility of psychedelic substances, like psilocybin, for disorders characterized by distortions of the self-experience, like depression. Accumulating preclinical evidence emphasizes the role of the glutamate system in the acute action of the drug on brain and behavior; however this has never been tested in humans. Following a double-blind, placebo-controlled, parallel group design, we utilized an ultra-high field multimodal brain imaging approach and demonstrated that psilocybin (0.17 mg/kg) induced region-dependent alterations in glutamate, which predicted distortions in the subjective experience of one’s self (ego dissolution). Whereas higher levels of medial prefrontal cortical glutamate were associated with negatively experienced ego dissolution, lower levels in hippocampal glutamate were associated with positively experienced ego dissolution. Such findings provide further insights into the underlying neurobiological mechanisms of the psychedelic, as well as the baseline, state. Importantly, they may also provide a neurochemical basis for therapeutic effects as witnessed in ongoing clinical trials.
Cannabis And Ketamine: Is There A Risk Of Interaction? June 22, 2020 | Used for thousands of years, cannabis ignites the CB1 and CB2 receptors, offering positive effects throughout the human body. Both help the body experience euphoria, and recently, researchers studied the use of both drugs to better understand their links and interactions. In 2015, the journal Biological Psychiatry found that one patient experienced an interaction with their bipolar drugs. While all drugs have the risk of interaction, a lack of available studies and research keep the specifics around drug interactions with cannabis difficult to pinpoint. According to the Multidisciplinary Association for Psychedelic Studies (MAPS), they believe both cannabis and ketamine have the potential to treat certain conditions, with some considerations.